Population outcomes of EBRT with LDR brachytherapy boost for intermediate, high-risk prostate cancer

被引：0
|
作者：
Oh, J. [1 ]
Spadinger, I. [2 ]
Lapointe, V. [1 ]
Morris, J. [1 ]
机构：
[1] BC Canc, Radiat Oncol, Vancouver, BC, Canada
[2] BC Canc, Med Phys, Vancouver, BC, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2020年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD-0670
引用
收藏
页码：S372 / S372
页数：1
相关论文
共 50 条
  • [1] Comparison of Long-term Outcomes for Patients with High-Risk Prostate Cancer Treated with EBRT Alone Versus Combination EBRT with a LDR Brachytherapy Boost
    Sanders, J.
    Peach, M. S.
    Schad, M. D.
    Bauer-Nilsen, K.
    Libby, B.
    Showalter, T. N.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E306 - E306
  • [2] Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost
    Moll, Matthias
    Magrowski, Lukasz
    Mittlboeck, Martina
    Heinzl, Harald
    Kirisits, Christian
    Ciepal, Jakub
    Masri, Oliwia
    Heilemann, Gerd
    Stando, Rafal
    Krzysztofiak, Tomasz
    Depowska, Gabriela
    d'Amico, Andrea
    Techmanski, Tomasz
    Kozub, Anna
    Majewski, Wojciech
    Suwinski, Rafal
    Wojcieszek, Piotr
    Sadowski, Jacek
    Widder, Joachim
    Goldner, Gregor
    Miszczyk, Marcin
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2024,
  • [3] THE ROLE OF CAPRA SCORE AS A PREDICTOR OF OUTCOMES IN HIGH-RISK PROSTATE CANCER PATIENTS TREATED WITH EBRT PLUS HDR BRACHYTHERAPY BOOST
    Vigneault, Eric
    Carignan, Damien
    Magnan, Sindy
    Despres, Philippe
    Martin, Andre-Guy
    Foster, William
    Lavallee, Marie-Claude
    Aubin, Sylviane
    Lacroix, Frederic
    Froment, Marie-Anne
    Cantin, Audrey
    Poulin, Eric
    Morales, Brandon
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 174 : S65 - S65
  • [4] Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy group
    Ka, Kanta
    Schiappa, Renaud
    Terlizzi, Mario
    Mallet, Frederic
    Martin, Etienne
    Chand, Marie -Eve
    Demogeot, Nicolas
    Peiffert, Didier
    Pommier, Pascal
    Quivrin, Magali
    Kissel, Manon
    Pasquier, Corentin
    Khalifa, Jonathan
    Bossi, Alberto
    Hannoun-Levi, Jean -Michel
    Blanchard, Pierre
    [J]. RADIOTHERAPY AND ONCOLOGY, 2023, 180
  • [5] Does brachytherapy boost improve biochemical control in intermediate and high-risk prostate cancer?
    Miszczyk, M.
    Jablonska, I.
    Krzysztofiak, T.
    Magrowski, L.
    Majewski, W.
    Suwinski, R.
    Masri, O.
    Ciepal, J.
    Depowska, G.
    Gmerek, M.
    Nowicka, E.
    Wojcieszek, P.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1115 - S1115
  • [6] Long-term outcomes of LDR compared to hypofractionated EBRT for intermediate-risk prostate cancer
    Salgado, N. Sanmamed
    Joseph, L.
    Crook, J.
    Borg, J.
    Chung, P.
    Warde, P.
    Di Tomasso, A.
    Berlin, A.
    Patel, M.
    Bayley, A.
    Catton, C.
    Helou, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S589 - S589
  • [7] External beam radiotherapy (EBRT) and high dose rate (HDR) brachytherapy for intermediate and high-risk prostate cancer: Whole pelvis or prostate-only EBRT?
    Tharmalingam, Hannah
    Tsang, Yatman
    Choudhury, Ananya
    Hoskin, Peter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [8] Comparing the Cost Effectiveness of Hypofractionated EBRT with High Dose Rate Brachytherapy Boost and Intensity Modulated Radiation Therapy for the Treatment of Intermediate/High-Risk Prostate Cancer
    Lanni, T. B.
    Ghilezan, M. I.
    Gustafson, G. S.
    Marvin, K. S.
    Ye, H.
    Martinez, A. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S359 - S359
  • [9] LDR monotherapy versus LDR boost for intermediate-risk prostate cancer: long-term outcomes
    Goni Ramirez, A.
    De Paula, B.
    Saenz de Urturi, E.
    Pastor Sanchis, V.
    Bartres, A.
    Egiguren, M.
    Pagola, M.
    Roura, D. A.
    Ayete, A.
    Palacios, S.
    Iceta, U.
    Gonzalez, L.
    Ortiz de Urbina, D. I.
    Alba, V.
    Erzilbengoa, M.
    Rosa Nieto, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S515 - S516
  • [10] External Beam Radiation Therapy (EBRT) and High-Dose-Rate (HDR) Brachytherapy for Intermediate and High-Risk Prostate Cancer: The Impact of EBRT Volume
    Tharmalingam, Hannah
    Tsang, Yatman
    Choudhury, Ananya
    Alonzi, Roberto
    Wylie, James
    Ahmed, Imtiaz
    Henry, Ann
    Heath, Catherine
    Hoskin, Peter J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (03): : 525 - 533
12345